English

NEOPHOTONICS CORP

EDGAR

NPTN Quarterly report (10-Q) · filed 2022-07-26

128 filing records in this dataset, filed from 2010-04-15 to 2022-07-26. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

95 million USD

2022 Q2 · USD

Exact inputs and evidence

Revenue: 95006000 USD Source

Operating margin

6.7%

2022 Q2 · %

Exact inputs and evidence

Operating Income: 6366000 USD Source
Revenue: 95006000 USD Source

Operating cash flow

1.36 million USD

2022 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -10077000 USD Source
Operating Cash Flow: -11439000 USD Source

Free cash flow

-1.8 million USD

2022 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -10077000 USD Source
Operating Cash Flow: -11439000 USD Source
Capital Expenditure: 5202000 USD Source
Capital Expenditure: 2043000 USD Source

Cash and cash equivalents: 77.1 million USD 2022-06-30 Source
Exact value

77079000 USD
Long-term debt including current maturities: 33.6 million USD 2020-12-31 Source
Exact value

33559000 USD
Shares outstanding: 53.6 million shares 2022-06-30 Source
Exact value

53568000 shares

Reported share-count change

2.86% · 1.49 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

52080000 shares · 2021-06-30· Source
53568000 shares · 2022-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

349 million USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Revenue: 83742000 USD · 2021-07-01 – 2021-09-30 Source
Revenue: 80612000 USD · 2021-10-01 – 2021-12-31 Source
Revenue: 89268000 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 95006000 USD · 2022-04-01 – 2022-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-07-26.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2021-12-31
Operating income: 11 of 11 periods available· newest 2021-12-31
Net income: 11 of 11 periods available· newest 2021-12-31
Operating cash flow: 11 of 11 periods available· newest 2021-12-31
Capital expenditure: 11 of 11 periods available· newest 2021-12-31
Total assets: 6 of 11 periods available· newest 2021-12-31
Total liabilities: 6 of 11 periods available· newest 2021-12-31
Current assets: 6 of 11 periods available· newest 2021-12-31
Current liabilities: 6 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2021-12-31
Long-term debt including current maturities: 5 of 11 periods available· newest 2020-12-31
Shares outstanding: 6 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-21.8%

Prior period

USD 371.16 million

2020-01-01 – 2020-12-31
Current period

USD 290.29 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

290289000 − 371163000 = -80874000 USD

371163000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
290289000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NEOPHOTONICS CORP · 2021-12-31 NEOPHOTONICS CORP (edgar:1227025) Year-over-year change in Revenue: -80874000 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 290289000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1522880 Filing: 000122702522000014 Input fundies:Revenue: 371163000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1524275 Filing: 000122702522000014
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 36.35 million

Prior period

−USD 4.37 million

2020-01-01 – 2020-12-31
Current period

−USD 40.72 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-40719000 − -4366000 = -36353000 USD

-4366000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-40719000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NEOPHOTONICS CORP · 2021-12-31 NEOPHOTONICS CORP (edgar:1227025) Year-over-year change in Net income: -36353000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -40719000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1661369 Filing: 000122702522000014 Input fundies:NetIncome: -4366000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1662561 Filing: 000122702522000014
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-137.5%

Prior period

USD 54.93 million

2020-01-01 – 2020-12-31
Current period

−USD 20.59 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-20587000 − 54930000 = -75517000 USD

54930000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-20587000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NEOPHOTONICS CORP · 2021-12-31 NEOPHOTONICS CORP (edgar:1227025) Year-over-year change in Operating cash flow: -75517000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -20587000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1280457 Filing: 000122702522000014 Input fundies:OperatingCashFlow: 54930000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1281511 Filing: 000122702522000014
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-17.1%

Prior period

USD 13.87 million

2020-01-01 – 2020-12-31
Current period

USD 11.5 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

11499000 − 13870000 = -2371000 USD

13870000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
11499000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NEOPHOTONICS CORP · 2021-12-31 NEOPHOTONICS CORP (edgar:1227025) Year-over-year change in Capital expenditure: -2371000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 11499000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1285015 Filing: 000122702522000014 Input fundies:CapitalExpenditure: 13870000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1286003 Filing: 000122702522000014
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 290.29 million 100% of revenue
Cost of revenue USD 222.7 million 77% of revenue
Operating expenses USD 105.42 million 36% of revenue
Operating income −USD 37.83 million −13% of revenue
Tax, interest and other Derived USD 2.89 million 1% of revenue
Net income −USD 40.72 million −14% of revenue

Cash

Operating cash flow −USD 20.59 million −7.1% of revenue
Capital expenditure USD 11.5 million 4% of revenue
Free cash flow Derived −USD 32.09 million −11% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Net loss: net income was −0% of revenue.
2017 Operating loss: operating costs were 118% of revenue.
2018 Operating loss: operating costs were 113% of revenue.
2019 Operating loss: operating costs were 104% of revenue.
2020 Net loss: net income was −1.2% of revenue.
2021 Operating loss: operating costs were 113% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	411423000	408404000 Derived	3019000	3224000 Derived	-205000	2143000 Derived	Source 2016-01-01 – 2016-12-31: 411423000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 3019000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -205000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 53836000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 51693000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	292894000	344258000 Derived	-51364000	1969000 Derived	-53333000	-80176000 Derived	Source 2017-01-01 – 2017-12-31: 292894000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -51364000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -53333000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -32767000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 47409000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	322540000	364198000 Derived	-41658000	1979000 Derived	-43637000	4728000 Derived	Source 2018-01-01 – 2018-12-31: 322540000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -41658000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -43637000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 19595000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 14867000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	356804000	371346000 Derived	-14542000	2534000 Derived	-17076000	25155000 Derived	Source 2019-01-01 – 2019-12-31: 356804000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -14542000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -17076000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 34687000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 9532000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	371163000	367597000 Derived	3566000	7932000 Derived	-4366000	41060000 Derived	Source 2020-01-01 – 2020-12-31: 371163000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 3566000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -4366000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 54930000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 13870000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	290289000	328119000 Derived	-37830000	2889000 Derived	-40719000	-32086000 Derived	Source 2021-01-01 – 2021-12-31: 290289000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -37830000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -40719000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -20587000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 11499000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 290.3M 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	411423000	Revenue: 411423000 Open source
20172017-12-31	Revenue	292894000	Revenue: 292894000 Open source
20182018-12-31	Revenue	322540000	Revenue: 322540000 Open source
20192019-12-31	Revenue	356804000	Revenue: 356804000 Open source
20202020-12-31	Revenue	371163000	Revenue: 371163000 Open source
20212021-12-31	Revenue	290289000	Revenue: 290289000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-21.8% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 411423000 Open source
20172017-12-31	Year over year	-28.8%	Revenue: 292894000 Open source Revenue: 411423000 Open source
20182018-12-31	Year over year	10.1%	Revenue: 322540000 Open source Revenue: 292894000 Open source
20192019-12-31	Year over year	10.6%	Revenue: 356804000 Open source Revenue: 322540000 Open source
20202020-12-31	Year over year	4%	Revenue: 371163000 Open source Revenue: 356804000 Open source
20212021-12-31	Year over year	-21.8%	Revenue: 290289000 Open source Revenue: 371163000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -13% 2021

Net margin -14% 2021

Free cash flow margin -11.1% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	0.7%	Operating Income: 3019000 Open source Revenue: 411423000 Open source
20172017-12-31	Operating margin	-17.5%	Operating Income: -51364000 Open source Revenue: 292894000 Open source
20182018-12-31	Operating margin	-12.9%	Operating Income: -41658000 Open source Revenue: 322540000 Open source
20192019-12-31	Operating margin	-4.1%	Operating Income: -14542000 Open source Revenue: 356804000 Open source
20202020-12-31	Operating margin	1%	Operating Income: 3566000 Open source Revenue: 371163000 Open source
20212021-12-31	Operating margin	-13%	Operating Income: -37830000 Open source Revenue: 290289000 Open source
20162016-12-31	Net margin	-0%	Net Income: -205000 Open source Revenue: 411423000 Open source
20172017-12-31	Net margin	-18.2%	Net Income: -53333000 Open source Revenue: 292894000 Open source
20182018-12-31	Net margin	-13.5%	Net Income: -43637000 Open source Revenue: 322540000 Open source
20192019-12-31	Net margin	-4.8%	Net Income: -17076000 Open source Revenue: 356804000 Open source
20202020-12-31	Net margin	-1.2%	Net Income: -4366000 Open source Revenue: 371163000 Open source
20212021-12-31	Net margin	-14%	Net Income: -40719000 Open source Revenue: 290289000 Open source
20162016-12-31	Free cash flow margin	0.5%	Revenue: 411423000 Open source Operating Cash Flow: 53836000 Open source Capital Expenditure: 51693000 Open source
20172017-12-31	Free cash flow margin	-27.4%	Revenue: 292894000 Open source Operating Cash Flow: -32767000 Open source Capital Expenditure: 47409000 Open source
20182018-12-31	Free cash flow margin	1.5%	Revenue: 322540000 Open source Operating Cash Flow: 19595000 Open source Capital Expenditure: 14867000 Open source
20192019-12-31	Free cash flow margin	7.1%	Revenue: 356804000 Open source Operating Cash Flow: 34687000 Open source Capital Expenditure: 9532000 Open source
20202020-12-31	Free cash flow margin	11.1%	Revenue: 371163000 Open source Operating Cash Flow: 54930000 Open source Capital Expenditure: 13870000 Open source
20212021-12-31	Free cash flow margin	-11.1%	Revenue: 290289000 Open source Operating Cash Flow: -20587000 Open source Capital Expenditure: 11499000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -20.6M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	53836000	Operating Cash Flow: 53836000 Open source
20172017-12-31	Operating cash flow	-32767000	Operating Cash Flow: -32767000 Open source
20182018-12-31	Operating cash flow	19595000	Operating Cash Flow: 19595000 Open source
20192019-12-31	Operating cash flow	34687000	Operating Cash Flow: 34687000 Open source
20202020-12-31	Operating cash flow	54930000	Operating Cash Flow: 54930000 Open source
20212021-12-31	Operating cash flow	-20587000	Operating Cash Flow: -20587000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -32.1M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	2143000	Operating Cash Flow: 53836000 Open source Capital Expenditure: 51693000 Open source
20172017-12-31	Free cash flow	-80176000	Operating Cash Flow: -32767000 Open source Capital Expenditure: 47409000 Open source
20182018-12-31	Free cash flow	4728000	Operating Cash Flow: 19595000 Open source Capital Expenditure: 14867000 Open source
20192019-12-31	Free cash flow	25155000	Operating Cash Flow: 34687000 Open source Capital Expenditure: 9532000 Open source
20202020-12-31	Free cash flow	41060000	Operating Cash Flow: 54930000 Open source Capital Expenditure: 13870000 Open source
20212021-12-31	Free cash flow	-32086000	Operating Cash Flow: -20587000 Open source Capital Expenditure: 11499000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

49.9% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	42.3%	Total Liabilities: 165482000 Open source Total Assets: 390887000 Open source
20172017-12-31	Liabilities / assets	51.7%	Total Liabilities: 208502000 Open source Total Assets: 402953000 Open source
20182018-12-31	Liabilities / assets	53%	Total Liabilities: 180336000 Open source Total Assets: 340576000 Open source
20192019-12-31	Liabilities / assets	52.1%	Total Liabilities: 174473000 Open source Total Assets: 334679000 Open source
20202020-12-31	Liabilities / assets	44.3%	Total Liabilities: 143257000 Open source Total Assets: 323664000 Open source
20212021-12-31	Liabilities / assets	49.9%	Total Liabilities: 152606000 Open source Total Assets: 305567000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.17× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	1.85×	Current Assets: 270796000 Open source Current Liabilities: 146328000 Open source
20172017-12-31	Current assets / current liabilities	1.72×	Current Assets: 264640000 Open source Current Liabilities: 153871000 Open source
20182018-12-31	Current assets / current liabilities	2×	Current Assets: 233205000 Open source Current Liabilities: 116383000 Open source
20192019-12-31	Current assets / current liabilities	2.12×	Current Assets: 230748000 Open source Current Liabilities: 109079000 Open source
20202020-12-31	Current assets / current liabilities	2.65×	Current Assets: 235581000 Open source Current Liabilities: 88824000 Open source
20212021-12-31	Current assets / current liabilities	2.17×	Current Assets: 230061000 Open source Current Liabilities: 105975000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2012 2012-01-01 – 2012-12-31	−USD 17.53 million Exact value Exact value: -17530000 USD 2012-01-01 – 2012-12-31: -17530000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOPHOTONICS CORP · 2012-12-31 NEOPHOTONICS CORP (edgar:1227025) Net Income: -17530000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17530000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#221677 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.	−USD 8.79 million Exact value Exact value: -8790000 USD 2012-01-01 – 2012-12-31: -8790000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOPHOTONICS CORP · 2012-12-31 NEOPHOTONICS CORP (edgar:1227025) Operating Cash Flow: -8790000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8790000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#257349 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.	USD 12.74 million Exact value Exact value: 12738000 USD 2012-01-01 – 2012-12-31: 12738000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOPHOTONICS CORP · 2012-12-31 NEOPHOTONICS CORP (edgar:1227025) Capital Expenditure: 12738000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12738000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#258022 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.	−USD 21.53 million Calculation and evidence -8790000 − 12738000 USD Exact free cash flow: -21528000 USD 2012-01-01 – 2012-12-31: -8790000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 12738000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOPHOTONICS CORP · 2012-12-31 NEOPHOTONICS CORP (edgar:1227025) Free cash flow: -21528000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8790000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#257349 Filing: 000156459015001751 Input fundies:CapitalExpenditure: 12738000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#258022 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 34.34 million Exact value Exact value: -34339000 USD 2013-01-01 – 2013-12-31: -34339000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOPHOTONICS CORP · 2013-12-31 NEOPHOTONICS CORP (edgar:1227025) Net Income: -34339000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34339000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#221523 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.	USD 4.51 million Exact value Exact value: 4511000 USD 2013-01-01 – 2013-12-31: 4511000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOPHOTONICS CORP · 2013-12-31 NEOPHOTONICS CORP (edgar:1227025) Operating Cash Flow: 4511000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4511000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#257099 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.	USD 19.57 million Exact value Exact value: 19566000 USD 2013-01-01 – 2013-12-31: 19566000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOPHOTONICS CORP · 2013-12-31 NEOPHOTONICS CORP (edgar:1227025) Capital Expenditure: 19566000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 19566000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#257811 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.	−USD 15.06 million Calculation and evidence 4511000 − 19566000 USD Exact free cash flow: -15055000 USD 2013-01-01 – 2013-12-31: 4511000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 19566000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOPHOTONICS CORP · 2013-12-31 NEOPHOTONICS CORP (edgar:1227025) Free cash flow: -15055000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4511000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#257099 Filing: 000156459015001751 Input fundies:CapitalExpenditure: 19566000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#257811 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 19.72 million Exact value Exact value: -19719000 USD 2014-01-01 – 2014-12-31: -19719000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOPHOTONICS CORP · 2014-12-31 NEOPHOTONICS CORP (edgar:1227025) Net Income: -19719000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19719000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#221369 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.	−USD 451,000 Exact value Exact value: -451000 USD 2014-01-01 – 2014-12-31: -451000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOPHOTONICS CORP · 2014-12-31 NEOPHOTONICS CORP (edgar:1227025) Operating Cash Flow: -451000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -451000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#256849 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.	USD 11.03 million Exact value Exact value: 11027000 USD 2014-01-01 – 2014-12-31: 11027000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOPHOTONICS CORP · 2014-12-31 NEOPHOTONICS CORP (edgar:1227025) Capital Expenditure: 11027000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11027000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#257600 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.	−USD 11.48 million Calculation and evidence -451000 − 11027000 USD Exact free cash flow: -11478000 USD 2014-01-01 – 2014-12-31: -451000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 11027000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOPHOTONICS CORP · 2014-12-31 NEOPHOTONICS CORP (edgar:1227025) Free cash flow: -11478000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -451000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#256849 Filing: 000156459015001751 Input fundies:CapitalExpenditure: 11027000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000156459015001751/nptn-20141231.xml#257600 Filing: 000156459015001751 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	USD 3.67 million Exact value Exact value: 3668000 USD 2015-01-01 – 2015-12-31: 3668000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOPHOTONICS CORP · 2015-12-31 NEOPHOTONICS CORP (edgar:1227025) Net Income: 3668000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3668000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702518000009/nptn-20171231.xml#513715 Filing: 000122702518000009 The citation records this snapshot. The page link may show a newer release later.	USD 26.14 million Exact value Exact value: 26138000 USD 2015-01-01 – 2015-12-31: 26138000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOPHOTONICS CORP · 2015-12-31 NEOPHOTONICS CORP (edgar:1227025) Operating Cash Flow: 26138000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 26138000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702518000009/nptn-20171231.xml#512869 Filing: 000122702518000009 The citation records this snapshot. The page link may show a newer release later.	USD 16.84 million Exact value Exact value: 16837000 USD 2015-01-01 – 2015-12-31: 16837000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOPHOTONICS CORP · 2015-12-31 NEOPHOTONICS CORP (edgar:1227025) Capital Expenditure: 16837000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16837000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702518000009/nptn-20171231.xml#539778 Filing: 000122702518000009 The citation records this snapshot. The page link may show a newer release later.	USD 9.3 million Calculation and evidence 26138000 − 16837000 USD Exact free cash flow: 9301000 USD 2015-01-01 – 2015-12-31: 26138000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 16837000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOPHOTONICS CORP · 2015-12-31 NEOPHOTONICS CORP (edgar:1227025) Free cash flow: 9301000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 26138000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702518000009/nptn-20171231.xml#512869 Filing: 000122702518000009 Input fundies:CapitalExpenditure: 16837000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702518000009/nptn-20171231.xml#539778 Filing: 000122702518000009 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 205,000 Exact value Exact value: -205000 USD 2016-01-01 – 2016-12-31: -205000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOPHOTONICS CORP · 2016-12-31 NEOPHOTONICS CORP (edgar:1227025) Net Income: -205000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -205000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702519000013/nptn-20181231.xml#514367 Filing: 000122702519000013 The citation records this snapshot. The page link may show a newer release later.	USD 53.84 million Exact value Exact value: 53836000 USD 2016-01-01 – 2016-12-31: 53836000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOPHOTONICS CORP · 2016-12-31 NEOPHOTONICS CORP (edgar:1227025) Operating Cash Flow: 53836000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 53836000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702519000013/nptn-20181231.xml#513522 Filing: 000122702519000013 The citation records this snapshot. The page link may show a newer release later.	USD 51.69 million Exact value Exact value: 51693000 USD 2016-01-01 – 2016-12-31: 51693000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOPHOTONICS CORP · 2016-12-31 NEOPHOTONICS CORP (edgar:1227025) Capital Expenditure: 51693000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 51693000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702519000013/nptn-20181231.xml#539648 Filing: 000122702519000013 The citation records this snapshot. The page link may show a newer release later.	USD 2.14 million Calculation and evidence 53836000 − 51693000 USD Exact free cash flow: 2143000 USD 2016-01-01 – 2016-12-31: 53836000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 51693000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOPHOTONICS CORP · 2016-12-31 NEOPHOTONICS CORP (edgar:1227025) Free cash flow: 2143000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 53836000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702519000013/nptn-20181231.xml#513522 Filing: 000122702519000013 Input fundies:CapitalExpenditure: 51693000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702519000013/nptn-20181231.xml#539648 Filing: 000122702519000013 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 53.33 million Exact value Exact value: -53333000 USD 2017-01-01 – 2017-12-31: -53333000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOPHOTONICS CORP · 2017-12-31 NEOPHOTONICS CORP (edgar:1227025) Net Income: -53333000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53333000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702520000025/nptn12311910ka.htm#1782242 Filing: 000122702520000025 The citation records this snapshot. The page link may show a newer release later.	−USD 32.77 million Exact value Exact value: -32767000 USD 2017-01-01 – 2017-12-31: -32767000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOPHOTONICS CORP · 2017-12-31 NEOPHOTONICS CORP (edgar:1227025) Operating Cash Flow: -32767000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32767000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702520000025/nptn12311910ka.htm#1398514 Filing: 000122702520000025 The citation records this snapshot. The page link may show a newer release later.	USD 47.41 million Exact value Exact value: 47409000 USD 2017-01-01 – 2017-12-31: 47409000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOPHOTONICS CORP · 2017-12-31 NEOPHOTONICS CORP (edgar:1227025) Capital Expenditure: 47409000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 47409000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702520000025/nptn12311910ka.htm#1402866 Filing: 000122702520000025 The citation records this snapshot. The page link may show a newer release later.	−USD 80.18 million Calculation and evidence -32767000 − 47409000 USD Exact free cash flow: -80176000 USD 2017-01-01 – 2017-12-31: -32767000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 47409000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOPHOTONICS CORP · 2017-12-31 NEOPHOTONICS CORP (edgar:1227025) Free cash flow: -80176000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32767000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702520000025/nptn12311910ka.htm#1398514 Filing: 000122702520000025 Input fundies:CapitalExpenditure: 47409000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702520000025/nptn12311910ka.htm#1402866 Filing: 000122702520000025 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 43.64 million Exact value Exact value: -43637000 USD 2018-01-01 – 2018-12-31: -43637000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOPHOTONICS CORP · 2018-12-31 NEOPHOTONICS CORP (edgar:1227025) Net Income: -43637000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43637000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702521000034/nptn-20201231.htm#1697315 Filing: 000122702521000034 The citation records this snapshot. The page link may show a newer release later.	USD 19.6 million Exact value Exact value: 19595000 USD 2018-01-01 – 2018-12-31: 19595000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOPHOTONICS CORP · 2018-12-31 NEOPHOTONICS CORP (edgar:1227025) Operating Cash Flow: 19595000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 19595000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702521000034/nptn-20201231.htm#1300117 Filing: 000122702521000034 The citation records this snapshot. The page link may show a newer release later.	USD 14.87 million Exact value Exact value: 14867000 USD 2018-01-01 – 2018-12-31: 14867000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOPHOTONICS CORP · 2018-12-31 NEOPHOTONICS CORP (edgar:1227025) Capital Expenditure: 14867000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14867000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702521000034/nptn-20201231.htm#1304525 Filing: 000122702521000034 The citation records this snapshot. The page link may show a newer release later.	USD 4.73 million Calculation and evidence 19595000 − 14867000 USD Exact free cash flow: 4728000 USD 2018-01-01 – 2018-12-31: 19595000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 14867000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOPHOTONICS CORP · 2018-12-31 NEOPHOTONICS CORP (edgar:1227025) Free cash flow: 4728000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 19595000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702521000034/nptn-20201231.htm#1300117 Filing: 000122702521000034 Input fundies:CapitalExpenditure: 14867000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702521000034/nptn-20201231.htm#1304525 Filing: 000122702521000034 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 17.08 million Exact value Exact value: -17076000 USD 2019-01-01 – 2019-12-31: -17076000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOPHOTONICS CORP · 2019-12-31 NEOPHOTONICS CORP (edgar:1227025) Net Income: -17076000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17076000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1663735 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.	USD 34.69 million Exact value Exact value: 34687000 USD 2019-01-01 – 2019-12-31: 34687000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOPHOTONICS CORP · 2019-12-31 NEOPHOTONICS CORP (edgar:1227025) Operating Cash Flow: 34687000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 34687000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1282561 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.	USD 9.53 million Exact value Exact value: 9532000 USD 2019-01-01 – 2019-12-31: 9532000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOPHOTONICS CORP · 2019-12-31 NEOPHOTONICS CORP (edgar:1227025) Capital Expenditure: 9532000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9532000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1286991 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.	USD 25.16 million Calculation and evidence 34687000 − 9532000 USD Exact free cash flow: 25155000 USD 2019-01-01 – 2019-12-31: 34687000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 9532000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOPHOTONICS CORP · 2019-12-31 NEOPHOTONICS CORP (edgar:1227025) Free cash flow: 25155000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 34687000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1282561 Filing: 000122702522000014 Input fundies:CapitalExpenditure: 9532000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1286991 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 4.37 million Exact value Exact value: -4366000 USD 2020-01-01 – 2020-12-31: -4366000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOPHOTONICS CORP · 2020-12-31 NEOPHOTONICS CORP (edgar:1227025) Net Income: -4366000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4366000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1662561 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.	USD 54.93 million Exact value Exact value: 54930000 USD 2020-01-01 – 2020-12-31: 54930000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOPHOTONICS CORP · 2020-12-31 NEOPHOTONICS CORP (edgar:1227025) Operating Cash Flow: 54930000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 54930000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1281511 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.	USD 13.87 million Exact value Exact value: 13870000 USD 2020-01-01 – 2020-12-31: 13870000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOPHOTONICS CORP · 2020-12-31 NEOPHOTONICS CORP (edgar:1227025) Capital Expenditure: 13870000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13870000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1286003 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.	USD 41.06 million Calculation and evidence 54930000 − 13870000 USD Exact free cash flow: 41060000 USD 2020-01-01 – 2020-12-31: 54930000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 13870000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOPHOTONICS CORP · 2020-12-31 NEOPHOTONICS CORP (edgar:1227025) Free cash flow: 41060000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 54930000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1281511 Filing: 000122702522000014 Input fundies:CapitalExpenditure: 13870000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1286003 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 40.72 million Exact value Exact value: -40719000 USD 2021-01-01 – 2021-12-31: -40719000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOPHOTONICS CORP · 2021-12-31 NEOPHOTONICS CORP (edgar:1227025) Net Income: -40719000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -40719000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1661369 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.	−USD 20.59 million Exact value Exact value: -20587000 USD 2021-01-01 – 2021-12-31: -20587000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOPHOTONICS CORP · 2021-12-31 NEOPHOTONICS CORP (edgar:1227025) Operating Cash Flow: -20587000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20587000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1280457 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.	USD 11.5 million Exact value Exact value: 11499000 USD 2021-01-01 – 2021-12-31: 11499000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOPHOTONICS CORP · 2021-12-31 NEOPHOTONICS CORP (edgar:1227025) Capital Expenditure: 11499000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11499000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1285015 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.	−USD 32.09 million Calculation and evidence -20587000 − 11499000 USD Exact free cash flow: -32086000 USD 2021-01-01 – 2021-12-31: -20587000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 11499000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOPHOTONICS CORP · 2021-12-31 NEOPHOTONICS CORP (edgar:1227025) Free cash flow: -32086000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1227025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20587000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1280457 Filing: 000122702522000014 Input fundies:CapitalExpenditure: 11499000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1227025/000122702522000014/nptn-20211231.htm#1285015 Filing: 000122702522000014 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

128 filings · 4,572 latest values · 4,572 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001227025, 1227025, NPTN, edgar:1227025

Also known as NEOPHOTONICS CORP, NeoPhotonics Corp

NEOPHOTONICS CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation